690 related articles for article (PubMed ID: 23301733)
41. Disclosing JAK/STAT links to cell adhesion and cell polarity.
Hombría JC; Sotillos S
Semin Cell Dev Biol; 2008 Aug; 19(4):370-8. PubMed ID: 18590829
[TBL] [Abstract][Full Text] [Related]
42. Antagonizing cytokine-mediated JAK-STAT signaling by porcine reproductive and respiratory syndrome virus.
Yang L; Zhang YJ
Vet Microbiol; 2017 Sep; 209():57-65. PubMed ID: 28069291
[TBL] [Abstract][Full Text] [Related]
43. Mutant calreticulin in myeloproliferative neoplasms.
How J; Hobbs GS; Mullally A
Blood; 2019 Dec; 134(25):2242-2248. PubMed ID: 31562135
[TBL] [Abstract][Full Text] [Related]
44. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines.
Samaan A; Mahana W
Immunol Lett; 2007 Apr; 109(2):113-9. PubMed ID: 17368812
[TBL] [Abstract][Full Text] [Related]
45. JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
Kleppe M; Kwak M; Koppikar P; Riester M; Keller M; Bastian L; Hricik T; Bhagwat N; McKenney AS; Papalexi E; Abdel-Wahab O; Rampal R; Marubayashi S; Chen JJ; Romanet V; Fridman JS; Bromberg J; Teruya-Feldstein J; Murakami M; Radimerski T; Michor F; Fan R; Levine RL
Cancer Discov; 2015 Mar; 5(3):316-31. PubMed ID: 25572172
[TBL] [Abstract][Full Text] [Related]
46. Comparative analysis of the JAK/STAT signaling through erythropoietin receptor and thrombopoietin receptor using a systems approach.
Won HH; Park I; Lee E; Kim JW; Lee D
BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S53. PubMed ID: 19208156
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
[TBL] [Abstract][Full Text] [Related]
48. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms and consequences of Jak-STAT signaling in the immune system.
Villarino AV; Kanno Y; O'Shea JJ
Nat Immunol; 2017 Mar; 18(4):374-384. PubMed ID: 28323260
[TBL] [Abstract][Full Text] [Related]
50. About combs, notches, and tumors: epigenetics meets signaling.
Merdes G; Paro R
Dev Cell; 2009 Oct; 17(4):440-2. PubMed ID: 19853558
[TBL] [Abstract][Full Text] [Related]
51. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
Montero P; Milara J; Roger I; Cortijo J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
Manea SA; Manea A; Heltianu C
Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
[TBL] [Abstract][Full Text] [Related]
53. Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.
Wang YH; Huang ML
Dev Dyn; 2010 Oct; 239(10):2522-33. PubMed ID: 20737505
[TBL] [Abstract][Full Text] [Related]
54. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling.
Chaimowitz NS; Forbes LR
Curr Opin Pediatr; 2019 Dec; 31(6):843-850. PubMed ID: 31693596
[TBL] [Abstract][Full Text] [Related]
55. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
Durham GA; Williams JJL; Nasim MT; Palmer TM
Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
[TBL] [Abstract][Full Text] [Related]
56. Interpreting mixed signals: the cell's cytokine conundrum.
Delgoffe GM; Murray PJ; Vignali DA
Curr Opin Immunol; 2011 Oct; 23(5):632-8. PubMed ID: 21852079
[TBL] [Abstract][Full Text] [Related]
57. How cells respond to interferons revisited: from early history to current complexity.
Stark GR
Cytokine Growth Factor Rev; 2007; 18(5-6):419-23. PubMed ID: 17683974
[TBL] [Abstract][Full Text] [Related]
58. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
Waldmann TA; Chen J
Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
[TBL] [Abstract][Full Text] [Related]
59. Evolution of JAK-STAT pathway components: mechanisms and role in immune system development.
Liongue C; O'Sullivan LA; Trengove MC; Ward AC
PLoS One; 2012; 7(3):e32777. PubMed ID: 22412924
[TBL] [Abstract][Full Text] [Related]
60. The regulation of JAKs in cytokine signaling and its breakdown in disease.
Hammarén HM; Virtanen AT; Raivola J; Silvennoinen O
Cytokine; 2019 Jun; 118():48-63. PubMed ID: 29685781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]